us-green-violet-circle

Services

Is your content review process fast enough?

Automated content review services for life sciences

The marketing of life sciences (LS) products comes with labor-intensive and costly medical, legal, and regulatory obligations—and AI-driven content review can help address them. Learn how our Digital Content Review Services powered by IntelliDoc™ can help LS companies reduce content review timelines and cost, empower personalization, and improve customer engagement, compliantly.

Diagnosing the challenges in LS product marketing

Modern approaches, such as consumer personalization and omnichannel engagement, require high volumes of marketing materials and rapid distribution. However, many enterprises lack the necessary process, technology, and talent, resulting in disjointed and slow processing times.

As the attention shifts toward AI-driven approaches, many organizations have yet to secure the foundational elements needed for execution—including digital asset management (DAM), consistent content tagging processes, and taxonomy alignment. These roadblocks are further intensified as regulations increasingly affect how products are advertised to the public. By streamlining content review workflows, LS organizations can drive positive patient outcomes and address compliance requirements along the way.

From risk to remedy

Regulatory and reputational risk can arise as manual processes are leveraged to address the LS industry’s extensive marketing content review requirements. As these risk factors grow and create intersecting challenges for marketers, AI-enabled content review is key to driving marketing value.

Our Digital Content Review Services powered by IntelliDoc™ enable risk mitigation for marketing materials within the LS industry. Our professionals leverage IntelliDoc, our technology solution fueled by machine learning and AI, to help scale automation throughout your content review cycle.

We can program repeatable processes, such as including applicable disclaimers and proper brand-name usage, to help establish resilient controls throughout your content review—and with the use of AI and large language models (LLMs), the solution evolves in value over time. And as regulations evolve, our team can set new rulesets to meet the marketing requirements for pharmaceutical, medical device, and other biotechnology products. By pairing our knowledgeable talent with our automation-fueled technology, we can help remedy content review challenges for LS organizations.

Want to learn more about our content review services?

Explore our content review services

${column1-large-text}

Quality assurance verification

Our team can automate quality content checks based on business rules by leveraging IntelliDoc to assess requirements in policies, brand standards, and also with external health authority requirements. This helps in finding errors prior to the medical, legal, and regulatory (MLR) submission.

${column2-large-text}

Reference tagging and linking

Intelligent reference tagging and linking helps verify claims made in marketing content and provides proper substantiation with up-to-date reference materials.

Our team gathers feedback from across the LS ecosystem to improve how the platform identifies and cites claims.

${column3-large-text}

Change impact tracking


IntelliDoc generates alerts when published content requires responses and revisions.

We assist business teams in sourcing and organizing relevant regulatory content and develop content templates.

${column4-large-text}

Reusable content identification

By facilitating third-party analysis of modular content, IntelliDoc helps identify when the content is assembled inappropriately.

Our professionals engage with content creation teams to maintain IntelliDoc’s compatibility with your systems and share insights from the platform.

Want to continue the conversation? Reach out to see how our team could help your LS enterprise optimize the content review journey with IntelliDoc.

Contacts

Bill Carter
Principal
Deloitte & Touche LLP
wcarter@deloitte.com
+1 949 610 2128

Mark Stevenson
AVP Data Science
Deloitte & Touche LLP
mastevenson@deloitte.com
+1 804 697 1681

Jonathan Russell
Product Lead
Deloitte & Touche LLP
jonrussell@deloitte.com
+1 213 434 8849

Sudeep Misra
Senior Manager
Deloitte & Touche LLP
sumisra@deloitte.com
+1 213 369 3252

Fullwidth SCC. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.